Implantation of Vascular Grafts Lined with Genetically Modified Endothelial Cells
- 16 June 1989
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 244 (4910) , 1344-1346
- https://doi.org/10.1126/science.2734614
Abstract
The possibility of using the vascular endothelial cell as a target for gene replacement therapy was explored. Recombinant retroviruses were used to transduce the lacZ gene into endothelial cells harvested from mongrel dogs. Prosthetic vascular grafts seeded with the genetically modified cells were implanted as carotid interposition grafts into the dogs from which the original cells were harvested. Analysis of the graft 5 weeks after implantation revealed genetically modified endothelial cells lining the luminal surface of the graft. This technology could be used in the treatment of atherosclerosis disease and the design of new drug delivery systems.This publication has 5 references indexed in Scilit:
- Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.Proceedings of the National Academy of Sciences, 1988
- Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.Proceedings of the National Academy of Sciences, 1988
- Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.Proceedings of the National Academy of Sciences, 1987
- The Preclotting of Porous Arterial ProsthesesAnnals of Surgery, 1978
- Interspecies Healing of Porous Arterial ProsthesesArchives of Surgery, 1974